LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
What is the latest Revenue of LASA SUPERGENERICS ?
Year | Revenue |
---|---|
Mar2024 | ₹104 Cr |
Mar2023 | ₹130 Cr |
Mar2022 | ₹137 Cr |
Mar2021 | ₹202 Cr |
Mar2020 | ₹167 Cr |
How is Revenue of LASA SUPERGENERICS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹104 Cr | -19.47 | |
Mar2023 | ₹130 Cr | -5.51 | |
Mar2022 | ₹137 Cr | -32.24 | |
Mar2021 | ₹202 Cr | 21.00 | |
Mar2020 | ₹167 Cr | - |
Compare Revenue of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹51.6 Cr | -4.1% | -14.7% | -57% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -4.1% |
-14.7% |
-57% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses